20.04.2017 • News

Toyota Boshoku and Mitsui in Plastics Alliance

(c) Nataliya Hora/Shutterstock
(c) Nataliya Hora/Shutterstock

Automotive component manufacturer Toyota Boshoku, part of the Toyota group, will partner with Mitsui Chemicals to commercialize a high impact-resistant plastic as a resin modifier.  Under a recently concluded license agreement, Mitsui Chemicals will use Toyota Boshoku’s patented technology to manufacture and market the plastic from 2018. The agreement follows a memorandum of understanding signed in November 2016.

Developed by Toyota Boshoku and Toyota Central R&D Labs, the material is a polymer alloy made from PA 11, PP and a Mitsui Chemicals’ compatibilizer. By controlling the phase structure of the PA and PP at the nano-level, an efficient impact absorbing structure is created that is claimed to achieve top level impact resistance.

Toyota Boshoku has developed a method of using the plastic as a resin modifier, not just for interior car parts such as seating and door trims but also for other automotive parts that demand high impact resistance. The parts maker believes its technology can contribute to increased safety in cars but also expects increasing applications in other non-automotive applications.

Mitsui Chemicals said it plans to also sell the plastic in the industrial and consumer goods markets and will use its technical expertise and sales channels in the years ahead to expand the material’s use as a modifier.  

Company

Logo:

Mitsui Chemicals Europe GmbH

Oststr. 34
40211 Düsseldorf
Germany

Company contact







Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.